International cooperation in biopharmaceutical development and preclinical veterinary CRO services

Centro de Biotecnología y Biomedicina SpA (CBB), based in Chile, is seeking international partners for collaborative projects focused on the development, formulation, characterization, and validation of innovative biopharmaceutical and veterinary products.

Our multidisciplinary team has experience in recombinant proteins, bioactive molecules, immunotherapies, veterinary products, pharmaceutical formulations, and biotechnology-based solutions. We support projects from early-stage development and formulation optimization to functional characterization, technological validation, and preclinical evaluation.

CBB also offers veterinary Contract Research Organization (CRO) services for preclinical, safety, toxicology, tolerability, and efficacy studies in animal models. Our animal research unit supports studies in rabbits and large-animal species, including sheep, pigs, chickens, turkeys, and cattle. Study protocols can be adapted to the characteristics, intended application, and development stage of each bioproduct.

We are interested in participating in international R&D and innovation consortia, bilateral projects, technology-development agreements, and validation studies. We aim to collaborate with biotechnology and pharmaceutical companies, veterinary health companies, universities, research centers, and technology providers seeking complementary capabilities for product development and preclinical validation.

Through these partnerships, we seek to accelerate the development of innovative bioproducts, reduce technological and preclinical risks, generate evidence supporting future regulatory and commercial strategies, and promote technology transfer with impact on human health, animal health, and sustainable production.